Cleantech Transit, Inc. (CLNO)
Biomass is the main source of energy for a large number of small, rural, and cottage industries along with the majority of rural households. The majority of these enterprises belong to an unstructured sector and hence information and data on these industries are scarce. These industries provide employment to millions of people and form a very important part of the rural economy. The biomass-consuming industries can be divided into two categories, namely traditional industries and new or potential industries.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
NetScout Systems Inc. (Nasdaq:NTCT) announced that it has completed its acquisition of privately held Fox Replay BV, a leading provider of session reconstruction and replay technology that enables organizations to perform forensic analysis of end-user actions in support of CyberIntelligence, Information Assurance, Lawful Intercept and general security practices.
NetScout Systems, Inc. engages in the design, development, manufacture, marketing, sale, and support of unified service delivery management, service assurance, and application and network performance management solutions worldwide.
Mitcham Industries Inc (Nasdaq:MIND) announced that it has opened a new warehouse, logistics and repair facility in Budapest, Hungary. Bill Mitcham, the Company’s President and CEO, stated, “We are extremely pleased to announce the opening of our new facility in Budapest.
Mitcham Industries, Inc., through its subsidiaries, engages in the leasing, manufacture, and sale of seismic equipment to the oil and gas industry worldwide. The company operates in two segments, Equipment Leasing and Seamap.
Enzo Biochem, Inc. (ENZ)
Biotechnology is technology based on biology, especially when used in agriculture, food science, and medicine. It may also be included under the very broad term bioengineering. One aspect of biotechnology is the directed use of organisms for the manufacture of organic products: examples include beer and milk products. For another example, naturally present bacteria are utilized by the mining industry in bioleaching. Biotechnology is also used to recycle, treat waste, cleanup sites contaminated by industrial activities (bioremediation), and produce biological weapons.
Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.
Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.
The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D’Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.
Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary’s operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo’s presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.
For more information about Enzo Biochem Inc. visit its website: http://www.enzo.com
MedAssets, Inc. (Nasdaq:MDAS) announced that it plans to release its financial results for the third quarter and nine-month period ended September 30, 2011 after 4:00 p.m. ET on Thursday, November 3, 2011.
MedAssets, Inc. provides technology enabled products and services for hospitals, health systems, and other non-acute healthcare providers in the United States. It operates in two segments, Spend and Clinical Resource Management, and Revenue Cycle Management.